Close

move up move left move right move bottom

XARELTO® Patient Stories

See why XARELTO® was the right choice for us

Brian Vickers — XARELTO® for DVT Blood Clots

"When I had my second blood clot, I talked to my doctor and learned more about XARELTO®, a latest-generation blood thinner."

 

NASCAR® driver Brian Vickers, who was sidelined by two blood clots, shares his experience of treating the first one with warfarin and the second with XARELTO®.

Katie Hoff — XARELTO® for PE

“I was excited when my doctor told me there were no known dietary restrictions and I wouldn’t need regular blood monitoring.”

Olympic medalist and Former World Champion Swimmer Katie Hoff shares her frightening experience with blood clots in her lung, and why she talked to her doctor about a latest-generation blood thinner.

 

Indications

 

IMPORTANT SAFETY INFORMATION

 

Indication and Important saftey Information

 

  • Reducing the risk of stroke and systemic embolism in patients with nonvalvular atrial fibrillation (AF). There are limited data on the relative effectiveness of XARELTO® (rivaroxaban) and warfarin in reducing the risk of stroke and systemic embolism when warfarin therapy is well controlled.
  • Treatment of deep vein thrombosis (DVT).
  • Treatment of pulmonary embolism (PE).
  • Reduction in the risk of recurrence of DVT and of PE following initial 6 months treatment for DVT and/or PE.
  • Prophylaxis of DVT, which may lead to PE in patients undergoing knee replacement surgery.
  • Prophylaxis of DVT, which may lead to PE in patients undergoing hip replacement surgery.